Reuters logo
BRIEF-Allergan announces settlement on Restasis patent litigation with Innopharma
2017年10月12日 / 晚上8点24分 / 9 天内

BRIEF-Allergan announces settlement on Restasis patent litigation with Innopharma

Oct 12 (Reuters) - Allergan Plc

* Allergan announces settlement on Restasis® (cyclosporine ophthalmic emulsion) 0.05% patent litigation with Innopharma, Inc.

* Allergan Plc - ‍additional details regarding settlement were not disclosed​

* Allergan Plc - ‍as a result of settlement, all Innopharma Hatch-Waxman litigation regarding Restasis patents will be dismissed​

* Allergan - will grant Innopharma licenses to market generic version of Restasis in U.S. beginning Feb 24, 2024, or earlier under certain circumstances​

* Allergan - ‍under certain circumstances, co will supply, authorize Innopharma to launch an authorized generic version of Restasis on August 28, 2024​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below